Takeda Pharmaceutical Non-GAAP EPS of ¥484.00, revenue of ¥4263.8B; initiates FY24 outlook

cryptocurrency 1 week ago
Flipboard
Takeda Pharmaceutical press release (NYSE:TAK): FY Non-GAAP EPS of ¥484.00. Revenue of ¥4263.8B +5.9% Y/Y. FY2024 Outlook (Billion yen) FY2024MANAGEMENT …
Read Entire Article